Consequently, FGD3 level is strongly correlated with cancer cell sensitivity to ErSO-induced lytic cell death in 2-dimensional (2D) cell culture, 3-dimensional (3D) patient-derived breast cancer organoids (PDOs) and orthotopic mouse xenografts. This evidence concerns the gene FGD3 and breast cancer.